FDA Inspection
Interstate Blood Bank Inc of MissouriInterstate Blood Bank Inc of Missouri – FDA Inspection, Aug 2, 2021
Record Details
This FDA Inspection record concerns Interstate Blood Bank Inc of Missouri, with an inspection on August 2, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 2, 2021
- Product Type
- Biologics
View Company Profile
ID · a4142cbf-8cbc-4a7e-bcc3-11ed33f45287
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1147661
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.160(a)(1)Concurrent documentation
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Interstate Blood Bank Inc of Missouri
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 19, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 16, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 11, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 20, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Interstate Blood Bank Inc of Missouri
- FDA Inspection 1077490 - 2018-12-19
- FDA Inspection 946197 - 2015-09-16
- FDA Inspection 814870 - 2013-01-11
- FDA Inspection 677474 - 2010-09-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.